AstraZeneca has rolled out a fresh TV spot for its blockbuster-to-be Breztri, hitting the me | AstraZeneca has rolled out a ...

While people with asthma or chronic obstructive pulmonary disease (COPD ... with the new propellant that will come down to 2 kilograms, Clow said. The dose, look and feel of the new inhalers ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...

The disease can be caused by long-term exposure to inhaled irritants, which is why it’s prevalent in smokers. But non-smokers can also develop COPD. Standard treatment includes drugs and drug ...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD exacerbations in some patients whose symptoms aren’t adequately controlled with inhaled medicines.

Marking the sixth indication for the drug, the approval provides a new option for the ... treatment for adults whose COPD is not well controlled with inhalers. The drug (generic name dupilumab ...

Large numbers of hospital admissions, along with poor adherence and the prescribing of inappropriate inhalers mean ... number of new drugs available for asthma and COPD, HCPs are increasingly ...